Saul Blecker1, Jeph Herrin2, Li Li3, Huihui Yu2, Jacqueline N Grady3, Leora I Horwitz4. 1. Department of Population Health, NYU School of Medicine, New York, New York; Department of Medicine, NYU School of Medicine, New York, New York; Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York, New York. Electronic address: Saul.blecker@nyumc.org. 2. Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut. 3. Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut. 4. Department of Population Health, NYU School of Medicine, New York, New York; Department of Medicine, NYU School of Medicine, New York, New York; Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York, New York.
Abstract
BACKGROUND: The Medicare Hospital Readmissions Reduction Program has led to fewer readmissions following hospitalizations with a principal diagnosis of heart failure (HF). Patients with HF are frequently hospitalized for other causes. OBJECTIVES: This study sought to compare trends in Medicare risk-adjusted, 30-day readmissions following principal HF hospitalizations and other hospitalizations with HF. METHODS: This was a retrospective study of 12,973,853 Medicare hospitalizations with a principal or secondary diagnosis of HF between January 2008 and June 2015. Hospitalizations were categorized as follows: principal HF hospitalizations; principal acute myocardial infarction or pneumonia hospitalizations with secondary HF; and other hospitalizations with secondary HF. The study examined trends in risk-adjusted, 30-day, all-cause readmission rates for each cohort and trends in differences in readmission rates among cohorts by using linear spline regression models. RESULTS: Before passage of the Affordable Care Act in March 2010, risk-adjusted, 30-day readmission rates were stable for all 3 cohorts, with mean monthly rates of 26.1%, 24.9%, and 24.4%, respectively. Risk-adjusted readmission rates started declining after passage of the Affordable Care Act by 1.09% (95% confidence interval [CI]: 0.51% to 1.68%), 1.24% (95% CI: 0.92% to 1.57%), and 1.05% (95% CI: 0.52% to 1.58%) per year, respectively, until implementation of the Hospital Readmissions Reduction Program in October 2012 and then stabilized for all 3 cohorts. CONCLUSIONS: Patients with HF are often hospitalized for other causes, and these hospitalizations have high readmission rates. Policy changes led to decreases in readmission rates for both principal and secondary HF hospitalizations. Readmission rates in both groups remain high, suggesting that initiatives targeting all hospitalized patients with HF continue to be warranted.
BACKGROUND: The Medicare Hospital Readmissions Reduction Program has led to fewer readmissions following hospitalizations with a principal diagnosis of heart failure (HF). Patients with HF are frequently hospitalized for other causes. OBJECTIVES: This study sought to compare trends in Medicare risk-adjusted, 30-day readmissions following principal HF hospitalizations and other hospitalizations with HF. METHODS: This was a retrospective study of 12,973,853 Medicare hospitalizations with a principal or secondary diagnosis of HF between January 2008 and June 2015. Hospitalizations were categorized as follows: principal HF hospitalizations; principal acute myocardial infarction or pneumonia hospitalizations with secondary HF; and other hospitalizations with secondary HF. The study examined trends in risk-adjusted, 30-day, all-cause readmission rates for each cohort and trends in differences in readmission rates among cohorts by using linear spline regression models. RESULTS: Before passage of the Affordable Care Act in March 2010, risk-adjusted, 30-day readmission rates were stable for all 3 cohorts, with mean monthly rates of 26.1%, 24.9%, and 24.4%, respectively. Risk-adjusted readmission rates started declining after passage of the Affordable Care Act by 1.09% (95% confidence interval [CI]: 0.51% to 1.68%), 1.24% (95% CI: 0.92% to 1.57%), and 1.05% (95% CI: 0.52% to 1.58%) per year, respectively, until implementation of the Hospital Readmissions Reduction Program in October 2012 and then stabilized for all 3 cohorts. CONCLUSIONS:Patients with HF are often hospitalized for other causes, and these hospitalizations have high readmission rates. Policy changes led to decreases in readmission rates for both principal and secondary HF hospitalizations. Readmission rates in both groups remain high, suggesting that initiatives targeting all hospitalized patients with HF continue to be warranted.
Authors: Harlan M Krumholz; Joan Amatruda; Grace L Smith; Jennifer A Mattera; Sarah A Roumanis; Martha J Radford; Paula Crombie; Viola Vaccarino Journal: J Am Coll Cardiol Date: 2002-01-02 Impact factor: 24.094
Authors: Faraz S Ahmad; Joshua P Metlay; Frances K Barg; Rebecca R Henderson; Rachel M Werner Journal: Am J Med Qual Date: 2012-11-01 Impact factor: 1.852
Authors: Ankur Gupta; Larry A Allen; Deepak L Bhatt; Margueritte Cox; Adam D DeVore; Paul A Heidenreich; Adrian F Hernandez; Eric D Peterson; Roland A Matsouaka; Clyde W Yancy; Gregg C Fonarow Journal: JAMA Cardiol Date: 2018-01-01 Impact factor: 14.676
Authors: Leora I Horwitz; Chohreh Partovian; Zhenqiu Lin; Jacqueline N Grady; Jeph Herrin; Mitchell Conover; Julia Montague; Chloe Dillaway; Kathleen Bartczak; Lisa G Suter; Joseph S Ross; Susannah M Bernheim; Harlan M Krumholz; Elizabeth E Drye Journal: Ann Intern Med Date: 2014-11-18 Impact factor: 25.391
Authors: Saul Blecker; Sunil K Agarwal; Patricia P Chang; Wayne D Rosamond; Donald E Casey; Anna Kucharska-Newton; Martha J Radford; Josef Coresh; Stuart Katz Journal: J Am Coll Cardiol Date: 2013-09-25 Impact factor: 24.094
Authors: Grace Y Jenq; Margaret M Doyle; Beverly M Belton; Jeph Herrin; Leora I Horwitz Journal: JAMA Intern Med Date: 2016-05-01 Impact factor: 21.873
Authors: Elizabeth H Bradley; Leslie Curry; Leora I Horwitz; Heather Sipsma; Yongfei Wang; Mary Norine Walsh; Don Goldmann; Neal White; Ileana L Piña; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2013-07
Authors: Elizabeth H Bradley; Heather Sipsma; Leora I Horwitz; Leslie Curry; Harlan M Krumholz Journal: JAMA Intern Med Date: 2014-01 Impact factor: 21.873
Authors: Madeline R Sterling; Nicola Dell; Benedetta Piantella; Jacklyn Cho; Harveen Kaur; Emily Tseng; Fabian Okeke; Mikaela Brown; Peggy B K Leung; Ariel F Silva; Amy L Shaw; Lisa M Kern Journal: J Gen Intern Med Date: 2020-06 Impact factor: 5.128
Authors: Yee Yin Hoo; Wardati Mazlan-Kepli; Wan Nurul Huda Wan Hasan; Fan Jie Chen; Prashanthini Devadas; Yan Yee Chow; Qian Yi Sow; Azrol Amar Azizan; Abdul Muizz Abd Malek; Glendon Seng Kiong Lau; Ping Lik Chua Journal: J Saudi Heart Assoc Date: 2020-12-03
Authors: Salik Nazir; Abdul Mannan Khan Minhas; Ishan S Kamat; Robert W Ariss; George V Moukarbel; Juan Carlos Plana Gomez; Savitri Fedson; Ajith Nair; Biykem Bozkurt; Hani Jneid Journal: Am J Med Date: 2021-06-30 Impact factor: 5.928